Pegaspargase

In the US, Pegaspargase (pegaspargase systemic) is a member of the drug class miscellaneous antineoplastics and is used to treat Acute Lymphoblastic Leukemia.

US matches:

• Pegaspargase


• Pegaspargase Intramuscular, Intravenous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XX24

CAS registry number (Chemical Abstracts Service)

0130167-69-0

Therapeutic Category

Antineoplastic agent

Chemical Names

Asparaginase, reaction product with succinic anhydride, esters with polyethylene glycol monomethyl ether

Poly{N-[alpha-methyl-omega-succinylpoly(oxyethylen)oxy]}sparaginase

Foreign Names

• Pegaspargasum (Latin)
• Pegaspargase (German)
• Pegaspargase (French)
• Pegaspargasa (Spanish)

Generic Names

• Pegaspargase (OS: USAN)
• PEG-L-asparaginase (IS)

Brand Names

• Oncaspar
  Enzon, United States; Filaxis, Argentina; Medac, Germany; Medac, Poland

International Drug Name Search

Glossary

IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.